Bryce Hoffman, MD
Allergy/Immunology · Los Gatos
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 2
- 2 carriers
- Offices
- 3
Offices
3 locations · Sutter Bay Medical Foundation · 3,783 clinicians in this group
Plans that list them
2 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Hoffman’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
2 of 2 plans
| Alignment Health Sutter Advantage +More (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
State licence records
1 licence
- Colorado DR.59247Physician · since 2017 · expires 2019-04-09Specialty on the licence: PediatricsExpiredNo board action on this licenceCheck it with the stateWhat they told the state about themselves
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Drugs they prescribed that Part D paid
$477,085
Pharmacies billed $477,085 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 934) in 2024. At or below the middle of the specialty; the typical allergy/ immunology clinician is at 0%.
693 generic and 241 brand-name prescriptions · $477,085 in drug cost · 14 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Dupixent | 41 | $147,052 | $3,587 |
| Fasenra | 27 | $145,172 | $5,377 |
| Spiriva Respimat | 60 | $37,462 | $624 |
| Breyna | 111 | $32,592 | $294 |
| Wixela Inhub | 38 | $8,006 | $211 |
See all 17 drugs
| Dupixent | 41 | $147,052 | $3,587 |
| Fasenra | 27 | $145,172 | $5,377 |
| Spiriva Respimat | 60 | $37,462 | $624 |
| Breyna | 111 | $32,592 | $294 |
| Wixela Inhub | 38 | $8,006 | $211 |
| Alvesco | 19 | $3,779 | $199 |
| Azelastine | 177 | $3,480 | $20 |
| Epinephrine | 24 | $3,079 | $128 |
| Fluticasone Propionate | 105 | $2,371 | $23 |
| Ipratropium | 41 | $869 | $21 |
| Montelukast | 71 | $787 | $11 |
| Albuterol Sulfate Hfa | 39 | $652 | $17 |
| Triamcinolone Acetonide | 19 | $330 | $17 |
| Hydroxyzine | 37 | $318 | $9 |
| Omeprazole | 19 | $164 | $9 |
| Doxepin | 11 | $163 | $15 |
| Prednisone | 17 | $147 | $9 |
Year by year
| 2024 | 934 | 217 | 0% (0) | 26% | $477,085 |
| 2023 | 929 | 213 | 0% (0) | None | $411,595 |
| 2022 | 797 | 184 | 0% (0) | 38% | $208,550 |
| 2021 | 567 | 151 | 0% (0) | 40% | $149,485 |
| 2020 | 344 | 87 | 0% (0) | 47% | $67,195 |
| 2019 | 47 | 19 | 0% (0) | 40% | $7,914 |
| 2018 | 12 | None | 0% (0) | None | $1,199 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Fasenra | 31 | $162,616 | $5,246 |
| Dupixent | 24 | $89,685 | $3,737 |
| Symbicort | 91 | $53,183 | $584 |
| Spiriva Respimat | 80 | $41,276 | $516 |
| Wixela Inhub | 30 | $5,740 | $191 |
| Epinephrine | 26 | $3,430 | $132 |
| Alvesco | 19 | $2,929 | $154 |
| Azelastine | 132 | $2,703 | $20 |
| Ipratropium | 47 | $1,705 | $36 |
| Fluticasone Propionate | 80 | $1,200 | $15 |
| Olopatadine | 47 | $1,011 | $22 |
| Albuterol Sulfate Hfa | 55 | $948 | $17 |
| Montelukast | 71 | $790 | $11 |
| Prednisone | 37 | $301 | $8 |
| Triamcinolone Acetonide | 15 | $256 | $17 |
| Hydroxyzine | 16 | $233 | $15 |
| Doxepin | 13 | $217 | $17 |
| Omeprazole | 14 | $135 | $10 |
2022: 17 drugs
| Fasenra | 15 | $73,969 | $4,931 |
| Symbicort | 98 | $50,826 | $519 |
| Spiriva Respimat | 78 | $30,756 | $394 |
| Wixela Inhub | 32 | $6,476 | $202 |
| Advair Hfa | 13 | $6,216 | $478 |
| Epinephrine | 31 | $3,676 | $119 |
| Azelastine | 127 | $2,651 | $21 |
| Ipratropium | 50 | $2,188 | $44 |
| Alvesco | 16 | $1,773 | $111 |
| Olopatadine | 51 | $1,078 | $21 |
| Fluticasone Propionate | 66 | $949 | $14 |
| Montelukast | 64 | $715 | $11 |
| Albuterol Sulfate Hfa | 30 | $550 | $18 |
| Triamcinolone Acetonide | 15 | $368 | $25 |
| Omeprazole | 23 | $220 | $10 |
| Prednisone | 22 | $183 | $8 |
| Hydroxyzine | 12 | $98 | $8 |
2021: 17 drugs
| Fasenra | 14 | $68,275 | $4,877 |
| Spiriva Respimat | 73 | $23,039 | $316 |
| Symbicort | 35 | $12,226 | $349 |
| Advair Hfa | 24 | $10,614 | $442 |
| Wixela Inhub | 38 | $6,796 | $179 |
| Alvesco | 28 | $3,333 | $119 |
| Epinephrine | 15 | $1,794 | $120 |
| Azelastine | 57 | $1,134 | $20 |
| Fluticasone Propionate | 52 | $713 | $14 |
| Ipratropium | 19 | $707 | $37 |
| Triamcinolone Acetonide | 16 | $621 | $39 |
| Montelukast | 33 | $366 | $11 |
| Albuterol Sulfate Hfa | 16 | $325 | $20 |
| Olopatadine | 21 | $301 | $14 |
| Prednisone | 27 | $292 | $11 |
| Omeprazole | 23 | $274 | $12 |
| Hydroxyzine | 14 | $124 | $9 |
2020: 12 drugs
| Advair Hfa | 27 | $12,262 | $454 |
| Spiriva Respimat | 39 | $10,324 | $265 |
| Advair Diskus | 20 | $3,913 | $196 |
| Alvesco | 19 | $2,118 | $111 |
| Azelastine | 50 | $1,037 | $21 |
| Ventolin Hfa | 18 | $997 | $55 |
| Ipratropium | 11 | $432 | $39 |
| Fluticasone Propionate | 29 | $379 | $13 |
| Montelukast | 21 | $227 | $11 |
| Prednisone | 13 | $175 | $13 |
| Omeprazole | 11 | $135 | $12 |
| Hydroxyzine | 11 | $95 | $9 |
Money from drug and device companies
$106 in 2023
| 2023 | 1 | 1 | None | $106 |
| 2022 | 2 | 7 | $5,060 | $6,056 |
| 2021 | 1 | 1 | None | $140 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Genentech | Xolair | $106 | 1 payment
|
See the published payment
| Genentech | Meals · 2023-05-17 | Xolair | $106 |
See earlier years (2022, 2021)
2022: $6,056
| Genentech | Xolair | $4,841 | 6 payments
|
| Genentech USA | Xolair | $1,215 | 1 payment
|
2021: $140
| GlaxoSmithKline | Nucala | $140 | 1 payment
|
Professional record
- NPI
- 1801216742
- Licence
- CO DR.0059247Colorado DR.59247: Expired
- Trained
- University of Texas Southwestern Medical School at Dallas, 2014
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207K00000X (207K00000X)
- Mailing address
- Po Box 276950, Sacramento, CA, 95827
- NPI first listed
- 2014-04-18
- NPI last updated
- 2025-07-14
- NPI record certified
- 2025-07-14
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.